Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer

被引：4
作者：
Rodriguez, Cesar A. [1 ]
Martin, Teresa [1 ]
Lozano, Rebeca [1 ]
Gomez, Amalia [1 ]
Cruz, Juan J. [1 ]
机构：
[1] Hosp Univ Salamanca IBSAL, Dept Med Oncol, Salamanca, Spain
来源：
BREAST JOURNAL | 2017年 / 23卷 / 06期
关键词：
bevacizumab; breast cancer; nasal septum perforation; SEPTUM PERFORATION; PACLITAXEL; THERAPY; TRIAL;
D O I：
10.1111/tbj.12913
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Nasal septum perforation in patients with cancer receiving systemic therapy is rare, and its association with bevacizumab use has described recently in the literature. Here, we report the case of a 34-year-old woman with hormone-sensitive, HER-2/neu negative, metastatic breast cancer who develope a nasal septum perforation during the treatment with paclitaxel and bevacizumab.
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
[41]   Perirenal hematoma in a patient treated with bevacizumab for metastatic colon cancer: A case report [J].
Lee, Min Sung ;
Shin, Il Sang ;
Kwun, Do Hyung ;
Kim, Se Hyung ;
Kim, Hyun Jung ;
Kim, Chan Kyu ;
Park, Seong Kyu ;
Hong, Dae Sik ;
Yun, Jina .
ONCOLOGY LETTERS, 2016, 11 (05) :3210-3212
[42]   Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab [J].
Roohullah, Aflah ;
Wong, Hui-Li ;
Sjoquist, Katrin M. ;
Gibbs, Peter ;
Field, Kathryn ;
Tran, Ben ;
Shapiro, Jeremy ;
Mckendrick, Joe ;
Yip, Desmond ;
Nott, Louise ;
Gebski, Val ;
Ng, Weng ;
Chua, Wei ;
Price, Timothy ;
Tebbutt, Niall ;
Chantrill, Lorraine .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (17) :5352-5358
[43]   Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis [J].
M. Di Salvatore ;
L. Lo Giudice ;
E. Rossi ;
C. Santonocito ;
G. Nazzicone ;
M. G. Rodriquenz ;
S. Cappuccio ;
A. Inno ;
P. Fuso ;
A. Orlandi ;
A. Strippoli ;
E. Capoluongo ;
A. Astone ;
A. Cassano ;
C. Barone .
Clinical and Translational Oncology, 2016, 18 :40-46
[44]   Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival [J].
Paiva, Tadeu Ferreira, Jr. ;
Fonseca de Jesus, Victor Hugo ;
Marques, Raul Amorim ;
Balieiro Anastacio da Costa, Alexandre Andre ;
de Macedo, Mariana Petaccia ;
Peresi, Patricia Maria ;
Damascena, Aline ;
Rossi, Benedito Mauro ;
Begnami, Maria Dirlei ;
Cordeiro de Lima, Vladmir Claudio .
BMC CANCER, 2015, 15
[45]   Effect of bevacizumab combined with docetaxel in the treatment of HER-2-negative recurrent metastatic breast cancer [J].
Wu, Ming ;
Gong, Jianming ;
Yu, Wei ;
Geng, Jinhong ;
Zeng, Linwen ;
Kong, Xiangdong .
JOURNAL OF BUON, 2020, 25 (04) :1814-1820
[46]   Adding Bevacizumab to Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer [J].
Fox, Kevin R. .
CURRENT ONCOLOGY REPORTS, 2009, 11 (01) :5-6
[47]   Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer [J].
Murillo, Serafin Morales ;
Cudos, Ariadna Gasol ;
Rodriguez, Joel Veas ;
Morales, Carles Canosa ;
Olive, Jordi Mele ;
Villellas, Felip Vilardell ;
Sanchez Guzman, Douglas Rene ;
Martinez, Edelmiro Iglesias ;
Salvia, Antonieta Salud .
FUTURE SCIENCE OA, 2021, 7 (03)
[48]   Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer [J].
Kevin R. Fox .
Current Oncology Reports, 2009, 11 :5-7
[49]   Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer [J].
Chan, A. ;
Miles, D. W. ;
Pivot, X. .
ANNALS OF ONCOLOGY, 2010, 21 (12) :2305-2315
[50]   Speckle-Tracking Echocardiography for Cardioncological Evaluation in Bevacizumab-Treated Colorectal Cancer Patients [J].
Andrea Sonaglioni ;
Adriana Albini ;
Emanuela Fossile ;
Maria Adelaide Pessi ;
Gian Luigi Nicolosi ;
Michele Lombardo ;
Claudio Anzà ;
Giuseppe Ambrosio .
Cardiovascular Toxicology, 2020, 20 :581-592
12345